Axonics Modulation Technologies: Funding & Investors (Oct 2026)
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
Axonics Modulation Technologies has raised $201M across 1 funding round on record, the most recent an undisclosed round of $201M announced in May 2021.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Axonics Modulation Technologies Company Profile and Key Stats
Latest funding round on record: May 2021.
Axonics Modulation Technologies Funding Rounds
Axonics Modulation Technologies Founders and Leadership Team
No contact details are on record for this team yet.
Axonics Modulation Technologies Funding Compared to Other Health Care Startups
Axonics Modulation Technologies' latest round of $201M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Axonics Modulation Technologies in Health Care and Irvine
Companies Similar to Axonics Modulation Technologies
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Axonics Modulation Technologies Funding FAQs
What does Axonics Modulation Technologies do?
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
How much funding has Axonics Modulation Technologies raised?
Axonics Modulation Technologies has raised $201M across 1 round on record. The most recent is an undisclosed round of $201M announced in May 2021.
When did Axonics Modulation Technologies last raise funding?
Axonics Modulation Technologies' most recent funding round on record is an undisclosed round of $201M, announced in May 2021.
Who is the CEO of Axonics Modulation Technologies?
Raymond W. Cohen is listed as CEO at Axonics Modulation Technologies.
Where is Axonics Modulation Technologies headquartered?
Axonics Modulation Technologies is based in Irvine, California, United States.
How many employees does Axonics Modulation Technologies have?
Axonics Modulation Technologies is in the 251-500 employee band.
How does Axonics Modulation Technologies' funding compare to other Health Care startups?
Axonics Modulation Technologies' latest round of $201M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Axonics Modulation Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Axonics Modulation Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.